Empagliflozin is a medication that is used to treat type 2 diabetes. It works by reducing the amount of glucose that is absorbed by the kidneys, which results in a decrease in blood sugar levels. Empagliflozin is known by the brand name Jardiance and is manufactured by Boehringer Ingelheim and Eli Lilly.

Type 2 diabetes is a chronic condition that affects millions of people around the world. It is characterized by high levels of glucose in the blood, which can lead to a range of complications including heart disease, kidney damage, nerve damage, and blindness. Diabetes is becoming increasingly common, in part due to the rise in obesity and sedentary lifestyles.

Empagliflozin is a relatively new medication, having been approved by the US Food and Drug Administration (FDA) in 2014. It is part of a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors, which also includes canagliflozin and dapagliflozin. These drugs work by blocking the action of SGLT2, a protein in the kidneys that is responsible for reabsorbing glucose from the urine.

One of the most significant benefits of empagliflozin is that it does not cause hypoglycemia (low blood sugar), which is a common problem with other diabetes medications. This is because empagliflozin does not stimulate the production of insulin, but rather works by reducing the amount of glucose that is absorbed by the kidneys. As a result, it is a safer medication for people with diabetes who are at risk of hypoglycemia.

Empagliflozin has also been shown to have a range of other benefits for people with type 2 diabetes. Studies have found that it can reduce the risk of heart attack, stroke, and cardiovascular death. This is because it lowers blood pressure and reduces the amount of glucose and lipids circulating in the blood. Additionally, empagliflozin has been shown to improve kidney function in people with diabetes, which is a common complication of the condition.

Despite its many benefits, empagliflozin is not suitable for everyone. It should not be used by people with type 1 diabetes or diabetic ketoacidosis, a serious complication of diabetes where the body produces high levels of ketones. It should also be used with caution in people with kidney or liver problems, as well as those taking certain medications such as diuretics.

The most common side effects of empagliflozin include urinary tract infections, genital yeast infections, and increased urination. These side effects are usually mild and can be managed with proper hygiene and medication. More serious side effects include low blood pressure, dehydration, and acute kidney injury, although these are rare.

If you have been diagnosed with type 2 diabetes or are at risk of developing the condition, you should speak to your healthcare provider to see if empagliflozin is right for you. It is a safe and effective medication that can help you manage your blood sugar levels and reduce your risk of complications. However, it is important to follow your healthcare provider’s instructions and monitor your blood sugar levels regularly to ensure that you are getting the best possible treatment.

Quest'articolo è stato scritto a titolo esclusivamente informativo e di divulgazione. Per esso non è possibile garantire che sia esente da errori o inesattezze, per cui l’amministratore di questo Sito non assume alcuna responsabilità come indicato nelle note legali pubblicate in Termini e Condizioni
Quanto è stato utile questo articolo?
0Vota per primo questo articolo!